Revenue for the quarter ended March 31 was $279 million, up from $251 million a year ago.
Analysts' estimates for the quarter were not readily available for comparison.
|-- Earnings Flash (AQS) AEQUUS PHARMACEUTICALS Repor...|
|Insider Buy: Bitnile Holdings|
|Insider Buy: Macerich|
|Insider Sell: Velodyne Lidar|
|Insider Sell: Xometry|